Published on 2 Mar 2024 on GuruFocus.com via Yahoo Finance
CEO & President Joshua Brumm Sells 100,000 Shares of Dyne Therapeutics Inc (DYN)
Joshua Brumm, CEO & President of Dyne Therapeutics Inc (NASDAQ:DYN), has sold 100,000 shares of the company on March 1, 2024, according to a recent SEC Filing. The transaction was executed at an average price of $28.96 per share, resulting in a total value of $2,896,000.
Warning! GuruFocus has detected 3 Warning Signs with DYN.
Dyne Therapeutics Inc (NASDAQ:DYN) is a biotechnology company focused on developing life-transforming therapies for patients with serious muscle diseases. The company leverages its proprietary FORCE platform to enhance the delivery of therapeutics to muscle tissues.